Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis
Background. Neurocysticercosis (NCC) is the commonest cause of childhood acquired epilepsy in developing countries. The use of cysticidal therapy in NCC, except “single lesion NCC,” is still debated in view of its doubtful usefulness and potential adverse effects. Methods. Children presenting with f...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | International Journal of Pediatrics |
| Online Access: | http://dx.doi.org/10.1155/2017/8983958 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849397098576871424 |
|---|---|
| author | Animesh Kumar Anirban Mandal Sheela Sinha Amitabh Singh Rashmi Ranjan Das |
| author_facet | Animesh Kumar Anirban Mandal Sheela Sinha Amitabh Singh Rashmi Ranjan Das |
| author_sort | Animesh Kumar |
| collection | DOAJ |
| description | Background. Neurocysticercosis (NCC) is the commonest cause of childhood acquired epilepsy in developing countries. The use of cysticidal therapy in NCC, except “single lesion NCC,” is still debated in view of its doubtful usefulness and potential adverse effects. Methods. Children presenting with first episode of seizure or acute focal neurological deficit without fever were screened for NCC and received appropriate therapy (followup done for 1 year to look for the response and side effects). Results. The prevalence of NCC was 4.5%. Most common presenting feature was generalized seizure and commonest imaging finding was single small enhancing lesion in the parietal lobe. Abnormal EEG and CSF abnormalities were found in almost half of the children. The response to therapy was very good with infrequent recurrence of seizure and adverse effects of therapy were encountered rarely. No risk factors for persistent seizure could be identified. Conclusion. Present study shows that the response to cysticidal therapy is very good in NCC as seizure recurrence was observed in only 5%, 4.2%, and 4.2% of cases at 3-month, 6-month, and 1-year followup. Adverse effects of therapy were observed in 20% of cases during therapy but they were mild and self-limiting. |
| format | Article |
| id | doaj-art-a92d0e42cc65446f91cc8e667b838549 |
| institution | Kabale University |
| issn | 1687-9740 1687-9759 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Pediatrics |
| spelling | doaj-art-a92d0e42cc65446f91cc8e667b8385492025-08-20T03:39:09ZengWileyInternational Journal of Pediatrics1687-97401687-97592017-01-01201710.1155/2017/89839588983958Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with NeurocysticercosisAnimesh Kumar0Anirban Mandal1Sheela Sinha2Amitabh Singh3Rashmi Ranjan Das4Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110029, IndiaDepartment of Pediatrics, Sitaram Bhartia Institute of Science and Research, New Delhi 110016, IndiaDepartment of Pediatrics, Patna Medical College and Hospital, Patna 800004, IndiaDepartment of Pediatrics, Chacha Nehru Bal Chikitsalaya, New Delhi 110031, IndiaDepartment of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar 751019, IndiaBackground. Neurocysticercosis (NCC) is the commonest cause of childhood acquired epilepsy in developing countries. The use of cysticidal therapy in NCC, except “single lesion NCC,” is still debated in view of its doubtful usefulness and potential adverse effects. Methods. Children presenting with first episode of seizure or acute focal neurological deficit without fever were screened for NCC and received appropriate therapy (followup done for 1 year to look for the response and side effects). Results. The prevalence of NCC was 4.5%. Most common presenting feature was generalized seizure and commonest imaging finding was single small enhancing lesion in the parietal lobe. Abnormal EEG and CSF abnormalities were found in almost half of the children. The response to therapy was very good with infrequent recurrence of seizure and adverse effects of therapy were encountered rarely. No risk factors for persistent seizure could be identified. Conclusion. Present study shows that the response to cysticidal therapy is very good in NCC as seizure recurrence was observed in only 5%, 4.2%, and 4.2% of cases at 3-month, 6-month, and 1-year followup. Adverse effects of therapy were observed in 20% of cases during therapy but they were mild and self-limiting.http://dx.doi.org/10.1155/2017/8983958 |
| spellingShingle | Animesh Kumar Anirban Mandal Sheela Sinha Amitabh Singh Rashmi Ranjan Das Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis International Journal of Pediatrics |
| title | Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis |
| title_full | Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis |
| title_fullStr | Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis |
| title_full_unstemmed | Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis |
| title_short | Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis |
| title_sort | prevalence response to cysticidal therapy and risk factors for persistent seizure in indian children with neurocysticercosis |
| url | http://dx.doi.org/10.1155/2017/8983958 |
| work_keys_str_mv | AT animeshkumar prevalenceresponsetocysticidaltherapyandriskfactorsforpersistentseizureinindianchildrenwithneurocysticercosis AT anirbanmandal prevalenceresponsetocysticidaltherapyandriskfactorsforpersistentseizureinindianchildrenwithneurocysticercosis AT sheelasinha prevalenceresponsetocysticidaltherapyandriskfactorsforpersistentseizureinindianchildrenwithneurocysticercosis AT amitabhsingh prevalenceresponsetocysticidaltherapyandriskfactorsforpersistentseizureinindianchildrenwithneurocysticercosis AT rashmiranjandas prevalenceresponsetocysticidaltherapyandriskfactorsforpersistentseizureinindianchildrenwithneurocysticercosis |